A COMPARISON OF SAFETY AND ACCEPTABILITY OF LEVONORGESTREL AND COPPER INTRAUTERINE DEVICES AMONG WOMEN LIVING WITH HIV/AIDS: A RANDOMIZED CONTROLED T

A COMPARISON OF SAFETY AND ACCEPTABILITY OF LEVONORGESTREL AND COPPER INTRAUTERINE DEVICES AMONG WOMEN LIVING WITH HIV/AIDS: A RANDOMIZED CONTROLED TRIAL.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201308000561212

Enrollment

634

Registered

2013-06-12

Start date

2013-07-15

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS Levenorgestrel intrauterine system and copper IUCD

Interventions

laboratory screening for STI

Syndromic screening for STI

Syndromic screening for ST

Levonorgestrel Intrauterine system (LNG_IU

Insertion of copper T 380A (Cu T 380A)

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: The study will include HIV positive women who are:- Undergoing care at MUJHU and MJAP clinics Wanting to prevent pregnancy Willing to be followed up Sexually active

Exclusion criteria

Exclusion criteria: The study will exclude HIV positive women who will be:- Unable to give informed consent, Have active PID. Has purulent or foul smelling cervico-vaginal discharge Has a history of STI within three months prior to the study. Has AIDS but not yet started on antiretroviral drugs Pregnant women

Design outcomes

Primary

Measure	Time frame
development of Pelvic inflamatory Disease (PID) ;DISCONTINUATION OF LNG-IUS AND COPPER T 380 A	—

Secondary

Measure	Time frame
IUD RELATED COMPLICATIONS eg AMENORRHEA, MENORRHAGIA, CRAMPING, EXPULSION, SEXUAL DYSFUNCTION, MENISTRUAL IRREGULARITIES,	—

Countries

Uganda

Contacts

Public ContactDan K Kaye

Chairman Doctoral commettee

dankkaye@yahoo.com+256 772 587952

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026